343544

Effectiveness of COVID-19 vaccination among patients hospitalized from April 2020 to March 2021: A Retrospective cohort study

Article

Last updated: 04 Jan 2025

Subjects

-

Tags

Infection prevention and control

Abstract

Background: The COVID-19 pandemic is one of the worst pandemics of recent times. Getting vaccinated against COVID-19 is a preventative strategy that helps in the prevention of the infection and reduces its severity. This study aimed to measure the reinfection and vaccination rates among COVID-19 patients who were admitted to Ain Shams University (ASU) Hospitals during the pre-vaccination era (April 2020–March 2021) and correlate their vaccination status with the incidence and severity of the reinfection. Methods: A retrospective cohort study was conducted that includes patients diagnosed with SARS-CoV-2 infection and admitted to ASU Hospitals during the pre-vaccination era. Data about the first COVID-19 infection were extracted from the patient's records and then a random sample of patients was selected and data about vaccination and re-infection rates were collected from them through an interview questionnaire. Results: 340 out of the 400 included subjects received COVID-19 vaccination (85%); 4.41% received incomplete doses; 67.06% received full vaccination; and 28.23% received full vaccination with an additional booster dose. 53.61% of booster vaccinations used the same vaccine each time, while 46.39% received different vaccines. Regarding the reinfection rate, it was higher among the unvaccinated group compared to the vaccinated (20% versus 13.82%) but this difference was not statistically significant. Also, the length of stay in hospital during the reinfection was 6 days in both groups.   Conclusion:  Although our results revealed no statistically significant difference between the vaccinated and unvaccinated groups regarding the reinfection rate. But it may show a piece of evidence that COVID-19 vaccination plays an important clinical role in reducing the severity of COVID-19 infection.

DOI

10.21608/mid.2024.265857.1776

Keywords

SARS-CoV-2 Efficiency, SARS-CoV-2 Vaccines, SARS-CoV-2 Re-infection, SARS-CoV-2 Immunization

Authors

First Name

Nehal

Last Name

Khater

MiddleName

Abdou Ali

Affiliation

Department of Community and Family Medicine, Faculty of Medicine, Misr University for Science and Technology, Egypt

Email

nehalkhater19571@yahoo.com

City

-

Orcid

-

First Name

Inas

Last Name

Ali

MiddleName

Abd El Rahim

Affiliation

Department of Community and Family Medicine, Faculty of Medicine, Misr University for Science and Technology, Egypt

Email

inas.abdelrahim@must.edu.eg

City

-

Orcid

-

First Name

Rasha

Last Name

Hussein

MiddleName

Saad

Affiliation

Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Egypt

Email

rasha_saad@med.asu.edu.eg

City

-

Orcid

-

First Name

Sahar

Last Name

Ibrahim

MiddleName

Khalil

Affiliation

Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Egypt

Email

saharkandil262@gmail.com

City

-

Orcid

-

First Name

Iman

Last Name

Bakr

MiddleName

Mohamed Ahmed

Affiliation

Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Egypt

Email

dreman_bakr@med.edu.eg

City

-

Orcid

-

Volume

5

Article Issue

2

Related Issue

47401

Issue Date

2024-05-01

Receive Date

2024-01-27

Publish Date

2024-05-01

Page Start

408

Page End

419

Print ISSN

2682-4132

Online ISSN

2682-4140

Link

https://mid.journals.ekb.eg/article_343544.html

Detail API

https://mid.journals.ekb.eg/service?article_code=343544

Order

2

Type

Original Article

Type Code

1,157

Publication Type

Journal

Publication Title

Microbes and Infectious Diseases

Publication Link

https://mid.journals.ekb.eg/

MainTitle

Effectiveness of COVID-19 vaccination among patients hospitalized from April 2020 to March 2021: A Retrospective cohort study

Details

Type

Article

Created At

25 Dec 2024